Inmed Pharmaceuticals (INM): 10% owner bought, ~$7.4K

~$7.4K
Approx. value · 5,601 sh @ $1.33: 941K
Holds after · shares reported

Traded: Oct 6, 2026
Filed: Oct 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 14, 2026Insider · 2 days before an 8-K10% owner purchased ~$37K of INM shares in the open market
Sep 15, 2026Insider · 1 day before an 8-K10% owner purchased ~$70K of INM shares in the open market
Sep 16, 2026Company filing · Form 8-K · Listing notice, Other newsReceived a notice from its stock exchange, and reported other company news“On September 16, 2026, InMed Pharmaceuticals Inc. (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying it that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in shareholders’ equity for continued listing.”
Sep 16, 2026Insider10% owner purchased ~$11K of INM shares in the open market
Oct 1, 2026Insider10% owner purchased ~$22K of INM shares in the open market
Oct 2, 2026Insider10% owner purchased ~$11K of INM shares in the open market
Oct 5, 2026Insider10% owner purchased ~$24K of INM shares in the open market
Oct 6, 2026 · this disclosureInsider10% owner purchased ~$7.4K of INM shares in the open market

What came next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Inmed Pharmaceuticals

For Inmed Pharmaceuticals, OQRO holds 16 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INM page.

Other recent filings by ADAR1 Capital Management, LLC, 10% owner

The full history of ADAR1 Capital Management, LLC, 10% owner is on the profile page.

Other disclosures at Inmed Pharmaceuticals

Everything OQRO holds on this company is on its INM page.

Inmed Pharmaceuticals (INM)10% owner bought ~$7.4K